fanta.bio Sample: CNhs11316
23601 enriched TFs, sorted by log₁₀ q-value (most significant first).
| TF | Cell Type | Active overlap | Inactive overlap | log₁₀ p-value | log₁₀ q-value | Fold-enrichment |
|---|---|---|---|---|---|---|
| TP53 SRX1547996 | Dermal fibroblast Epidermis | 969 / 8593 (11.3%) | 242 / 85930 (0.3%) | −324.0 | −324.0 | 40.04 |
| TP53 SRX19538279 | Osteoblasts Bone | 449 / 8593 (5.2%) | 138 / 85930 (0.2%) | −324.0 | −324.0 | 32.54 |
| HIF1A SRX11007095 | HK-2 Kidney | 1738 / 8593 (20.2%) | 561 / 85930 (0.7%) | −324.0 | −324.0 | 30.98 |
| TP53 SRX1547998 | Dermal fibroblast Epidermis | 1363 / 8593 (15.9%) | 446 / 85930 (0.5%) | −324.0 | −324.0 | 30.56 |
| DVL1 SRX22740968 | MDA-MB-231 Breast | 1211 / 8593 (14.1%) | 456 / 85930 (0.5%) | −324.0 | −324.0 | 26.56 |
| DVL1 SRX22740969 | MDA-MB-231 Breast | 1660 / 8593 (19.3%) | 703 / 85930 (0.8%) | −324.0 | −324.0 | 23.61 |
| DVL1 SRX22740970 | MDA-MB-231 Breast | 1610 / 8593 (18.7%) | 689 / 85930 (0.8%) | −324.0 | −324.0 | 23.37 |
| SCML2 SRX644728 | 293 Kidney | 1034 / 8593 (12.0%) | 445 / 85930 (0.5%) | −324.0 | −324.0 | 23.24 |
| FOXP1 SRX736067 | LNCAP Prostate | 1133 / 8593 (13.2%) | 719 / 85930 (0.8%) | −324.0 | −324.0 | 15.76 |
| MYH11 SRX265221 | ME-1 Blood | 564 / 8593 (6.6%) | 359 / 85930 (0.4%) | −324.0 | −324.0 | 15.71 |
| BRD4 SRX9419935 | BT-474 Breast | 2212 / 8593 (25.7%) | 1714 / 85930 (2.0%) | −324.0 | −324.0 | 12.91 |
| MED1 SRX9419944 | BT-474 Breast | 2128 / 8593 (24.8%) | 1673 / 85930 (1.9%) | −324.0 | −324.0 | 12.72 |
| BRD4 SRX9419937 | BT-474 Breast | 2184 / 8593 (25.4%) | 1734 / 85930 (2.0%) | −324.0 | −324.0 | 12.60 |
| MED1 SRX9419945 | BT-474 Breast | 2174 / 8593 (25.3%) | 1733 / 85930 (2.0%) | −324.0 | −324.0 | 12.54 |
| BRD4 SRX9419936 | BT-474 Breast | 2218 / 8593 (25.8%) | 1801 / 85930 (2.1%) | −324.0 | −324.0 | 12.32 |
| MED1 SRX9419946 | BT-474 Breast | 2203 / 8593 (25.6%) | 1814 / 85930 (2.1%) | −324.0 | −324.0 | 12.14 |
| BRD4 SRX9419938 | BT-474 Breast | 2181 / 8593 (25.4%) | 1810 / 85930 (2.1%) | −324.0 | −324.0 | 12.05 |
| MED1 SRX9419947 | BT-474 Breast | 2112 / 8593 (24.6%) | 1758 / 85930 (2.0%) | −324.0 | −324.0 | 12.01 |
| BRD4 SRX736201 | 90-8TL Neural | 3753 / 8593 (43.7%) | 3755 / 85930 (4.4%) | −324.0 | −324.0 | 9.99 |
| EZH2 SRX2146136 | LNCAP Prostate | 4489 / 8593 (52.2%) | 4759 / 85930 (5.5%) | −324.0 | −324.0 | 9.43 |
| Epitope tags SRX20419389 | Keratinocytes Epidermis | 1165 / 8593 (13.6%) | 1468 / 85930 (1.7%) | −324.0 | −324.0 | 7.94 |
| CHD1 SRX2268291 | Mesenchymal stem cells Others | 969 / 8593 (11.3%) | 1920 / 85930 (2.2%) | −304.6 | −301.4 | 5.05 |
| TP53 SRX19538274 | U2OS Bone | 365 / 8593 (4.2%) | 80 / 85930 (0.1%) | −296.6 | −293.5 | 45.63 |
| TP53 SRX19538268 | U2OS Bone | 366 / 8593 (4.3%) | 90 / 85930 (0.1%) | −290.8 | −287.6 | 40.67 |
| TP53 SRX19538276 | U2OS Bone | 364 / 8593 (4.2%) | 89 / 85930 (0.1%) | −289.5 | −286.4 | 40.90 |
| CTNNB1 SRX13991431 | MCF 10A Breast | 364 / 8593 (4.2%) | 105 / 85930 (0.1%) | −279.4 | −276.2 | 34.67 |
| BRD4 SRX736204 | 90-8TL Neural | 799 / 8593 (9.3%) | 1405 / 85930 (1.6%) | −275.5 | −272.4 | 5.69 |
| TP53 SRX19538280 | Osteoblasts Bone | 360 / 8593 (4.2%) | 110 / 85930 (0.1%) | −272.6 | −269.5 | 32.73 |
| TP53 SRX19538281 | Osteoblasts Bone | 379 / 8593 (4.4%) | 151 / 85930 (0.2%) | −267.9 | −264.8 | 25.10 |
| IRF3 SRX11453858 | Hep G2 Liver | 304 / 8593 (3.5%) | 40 / 85930 (0.0%) | −267.8 | −264.8 | 76.00 |
| TP53 SRX19538267 | U2OS Bone | 328 / 8593 (3.8%) | 73 / 85930 (0.1%) | −265.6 | −262.6 | 44.93 |
| TP53 SRX19538275 | U2OS Bone | 331 / 8593 (3.9%) | 88 / 85930 (0.1%) | −258.5 | −255.5 | 37.61 |
| TP53 SRX19538269 | U2OS Bone | 403 / 8593 (4.7%) | 224 / 85930 (0.3%) | −256.3 | −253.3 | 17.99 |
| TP53 SRX19538273 | U2OS Bone | 322 / 8593 (3.7%) | 79 / 85930 (0.1%) | −255.8 | −252.8 | 40.76 |
| HIF1A SRX20663235 | HK-2 Kidney | 357 / 8593 (4.2%) | 166 / 85930 (0.2%) | −240.8 | −237.8 | 21.51 |
| KAT6A SRX20971022 | Fibroblasts Others | 268 / 8593 (3.1%) | 30 / 85930 (0.0%) | −240.8 | −237.8 | 89.33 |
| CHD1 SRX2268289 | Mesenchymal stem cells Others | 495 / 8593 (5.8%) | 509 / 85930 (0.6%) | −240.6 | −237.6 | 9.72 |
| AGO2 SRX4708039 | Hep G2 Liver | 1229 / 8593 (14.3%) | 3853 / 85930 (4.5%) | −237.9 | −235.0 | 3.19 |
| TP53 SRX19538270 | U2OS Bone | 374 / 8593 (4.4%) | 227 / 85930 (0.3%) | −230.2 | −227.2 | 16.48 |
| IRF3 SRX11453861 | Hep G2 Liver | 262 / 8593 (3.0%) | 38 / 85930 (0.0%) | −227.6 | −224.7 | 68.95 |
| HMGB1 SRX2765964 | HUVEC Cardiovascular | 971 / 8593 (11.3%) | 2683 / 85930 (3.1%) | −217.2 | −214.3 | 3.62 |
| TP53 SRX19538271 | U2OS Bone | 500 / 8593 (5.8%) | 629 / 85930 (0.7%) | −216.1 | −213.2 | 7.95 |
| TP53 SRX19538282 | Osteoblasts Bone | 323 / 8593 (3.8%) | 166 / 85930 (0.2%) | −210.8 | −207.9 | 19.46 |
| CHD1 SRX2268290 | Mesenchymal stem cells Others | 455 / 8593 (5.3%) | 511 / 85930 (0.6%) | −210.3 | −207.4 | 8.90 |
| CEBPB SRX11379518 | Liposarcoma, Myxoid Adipocyte | 631 / 8593 (7.3%) | 1157 / 85930 (1.3%) | −208.8 | −205.9 | 5.45 |
| AR SRX10820653 | LNCAP Prostate | 286 / 8593 (3.3%) | 102 / 85930 (0.1%) | −208.1 | −205.2 | 28.04 |
| RUNX1 SRX2513054 | 293 Kidney | 1905 / 8593 (22.2%) | 9112 / 85930 (10.6%) | −186.1 | −183.2 | 2.09 |
| 5-mC SRX882970 | LNCAP Prostate | 1706 / 8593 (19.9%) | 7860 / 85930 (9.1%) | −178.0 | −175.2 | 2.17 |
| AR SRX10820651 | LNCAP Prostate | 278 / 8593 (3.2%) | 158 / 85930 (0.2%) | −175.0 | −172.2 | 17.59 |
| 5-mC SRX882968 | LNCAP Prostate | 1674 / 8593 (19.5%) | 7759 / 85930 (9.0%) | −172.0 | −169.2 | 2.16 |
| DNMT3B SRX3275107 | iPS cells Pluripotent stem cell | 403 / 8593 (4.7%) | 520 / 85930 (0.6%) | −171.0 | −168.2 | 7.75 |
| PBX4 SRX2731658 | PC-3 Prostate | 476 / 8593 (5.5%) | 13399 / 85930 (15.6%) | −170.7 | −167.9 | 0.36 |
| EED SRX8175103 | ES cells Pluripotent stem cell | 1252 / 8593 (14.6%) | 4968 / 85930 (5.8%) | −168.8 | −166.0 | 2.52 |
| TP53 SRX19538272 | U2OS Bone | 420 / 8593 (4.9%) | 590 / 85930 (0.7%) | −168.6 | −165.8 | 7.12 |
| CARM1 SRX10562203 | MDA-MB-231 Breast | 219 / 8593 (2.5%) | 68 / 85930 (0.1%) | −164.9 | −162.1 | 32.21 |
| AGO2 SRX6783957 | Hep G2 Liver | 800 / 8593 (9.3%) | 2351 / 85930 (2.7%) | −164.5 | −161.7 | 3.40 |
| YY1 SRX13585223 | NCCIT Pluripotent stem cell | 761 / 8593 (8.9%) | 2145 / 85930 (2.5%) | −164.4 | −161.7 | 3.55 |
| AGO2 SRX6783958 | Hep G2 Liver | 785 / 8593 (9.1%) | 2308 / 85930 (2.7%) | −161.2 | −158.4 | 3.40 |
| 5-mC SRX882965 | LNCAP Prostate | 1384 / 8593 (16.1%) | 6050 / 85930 (7.0%) | −157.2 | −154.4 | 2.29 |
| SOX2 SRX2731713 | Lung cancer cell line Lung | 192 / 8593 (2.2%) | 45 / 85930 (0.1%) | −153.8 | −151.0 | 42.67 |
| CIC SRX13262055 | Astrocytes Neural | 1726 / 8593 (20.1%) | 8554 / 85930 (10.0%) | −152.8 | −150.1 | 2.02 |
| STAT5B SRX831881 | CD8+ T cells Blood | 205 / 8593 (2.4%) | 69 / 85930 (0.1%) | −151.3 | −148.6 | 29.71 |
| Epitope tags SRX10549776 | K-562 Blood | 839 / 8593 (9.8%) | 2728 / 85930 (3.2%) | −151.0 | −148.3 | 3.08 |
| BMI1 SRX644729 | 293 Kidney | 199 / 8593 (2.3%) | 67 / 85930 (0.1%) | −146.9 | −144.2 | 29.70 |
| DNA-RNA hybrid SRX21658478 | U2OS Bone | 415 / 8593 (4.8%) | 713 / 85930 (0.8%) | −143.7 | −141.0 | 5.82 |
| DNMT3B SRX3275108 | iPS cells Pluripotent stem cell | 305 / 8593 (3.5%) | 333 / 85930 (0.4%) | −142.8 | −140.1 | 9.16 |
| SSRP1 SRX3436567 | HT-1080 Bone | 276 / 8593 (3.2%) | 263 / 85930 (0.3%) | −139.0 | −136.3 | 10.49 |
| HMGB1 SRX10567335 | HUVEC Cardiovascular | 828 / 8593 (9.6%) | 2824 / 85930 (3.3%) | −139.0 | −136.3 | 2.93 |
| LEO1 SRX1873456 | SEM Blood | 879 / 8593 (10.2%) | 3144 / 85930 (3.7%) | −137.7 | −135.0 | 2.80 |
| DNA-RNA hybrid SRX21658481 | U2OS Bone | 419 / 8593 (4.9%) | 788 / 85930 (0.9%) | −134.8 | −132.1 | 5.32 |
| SREBF2 SRX5359048 | HCC70 Breast | 977 / 8593 (11.4%) | 3872 / 85930 (4.5%) | −129.7 | −127.1 | 2.52 |
| EED SRX8175102 | ES cells Pluripotent stem cell | 990 / 8593 (11.5%) | 4002 / 85930 (4.7%) | −126.9 | −124.3 | 2.47 |
| NFYB SRX16608147 | HeLa Uterus | 196 / 8593 (2.3%) | 104 / 85930 (0.1%) | −126.4 | −123.8 | 18.85 |
| KAT7 SRX101303 | RKO Digestive tract | 766 / 8593 (8.9%) | 2649 / 85930 (3.1%) | −125.5 | −122.9 | 2.89 |
| TRP47 SRX4548329 | THP-1 Blood | 1427 / 8593 (16.6%) | 7114 / 85930 (8.3%) | −121.6 | −119.0 | 2.01 |
| TRIM25 SRX1660873 | Breast cancer cells Breast | 1096 / 8593 (12.8%) | 4799 / 85930 (5.6%) | −121.5 | −118.9 | 2.28 |
| BRPF3 SRX796085 | RKO Digestive tract | 615 / 8593 (7.2%) | 1854 / 85930 (2.2%) | −121.3 | −118.7 | 3.32 |
| FOXA1 SRX4815198 | MCF-7 Breast | 519 / 8593 (6.0%) | 12330 / 85930 (14.3%) | −121.3 | −118.6 | 0.42 |
| ERG SRX026653 | CD34 Hematopoietic stem cells Blood | 932 / 8593 (10.8%) | 3759 / 85930 (4.4%) | −119.6 | −117.0 | 2.48 |
| CNOT3 SRX886405 | HCT 116 Digestive tract | 1072 / 8593 (12.5%) | 4677 / 85930 (5.4%) | −119.5 | −116.9 | 2.29 |
| BRD1 SRX286203 | RKO Digestive tract | 668 / 8593 (7.8%) | 2174 / 85930 (2.5%) | −118.9 | −116.3 | 3.07 |
| FOXA1 SRX176862 | MCF-7 Breast | 181 / 8593 (2.1%) | 6950 / 85930 (8.1%) | −117.4 | −114.8 | 0.26 |
| BMI1 SRX7196715 | SU-DIPG-IV Neural | 1014 / 8593 (11.8%) | 4333 / 85930 (5.0%) | −117.3 | −114.7 | 2.34 |
| MITF SRX1555436 | 501A Epidermis | 1090 / 8593 (12.7%) | 4841 / 85930 (5.6%) | −117.3 | −114.7 | 2.25 |
| BRPF3 SRX796084 | RKO Digestive tract | 831 / 8593 (9.7%) | 3180 / 85930 (3.7%) | −116.2 | −113.6 | 2.61 |
| DNA-RNA hybrid SRX20083260 | SH-SY5Y Neural | 529 / 8593 (6.2%) | 1469 / 85930 (1.7%) | −115.2 | −112.6 | 3.60 |
| ESR1 SRX371469 | MCF-7 Breast | 141 / 8593 (1.6%) | 6159 / 85930 (7.2%) | −115.1 | −112.5 | 0.23 |
| ESR1 SRX371478 | MCF-7 Breast | 186 / 8593 (2.2%) | 6916 / 85930 (8.0%) | −113.4 | −110.8 | 0.27 |
| FOS SRX150477 | MCF 10A Breast | 372 / 8593 (4.3%) | 9886 / 85930 (11.5%) | −113.0 | −110.4 | 0.38 |
| DNA-RNA hybrid SRX21658480 | U2OS Bone | 342 / 8593 (4.0%) | 631 / 85930 (0.7%) | −111.6 | −109.0 | 5.42 |
| BRPF3 SRX796086 | RKO Digestive tract | 792 / 8593 (9.2%) | 3016 / 85930 (3.5%) | −111.4 | −108.9 | 2.63 |
| FOS SRX150478 | MCF 10A Breast | 391 / 8593 (4.6%) | 10114 / 85930 (11.8%) | −111.3 | −108.7 | 0.39 |
| DNA-RNA hybrid SRX20083265 | SH-SY5Y Neural | 464 / 8593 (5.4%) | 1183 / 85930 (1.4%) | −111.2 | −108.7 | 3.92 |
| FOXA1 SRX1161177 | MCF-7 Breast | 143 / 8593 (1.7%) | 6042 / 85930 (7.0%) | −109.8 | −107.3 | 0.24 |
| MECOM SRX23677896 | HNT-34 Blood | 1166 / 8593 (13.6%) | 5525 / 85930 (6.4%) | −109.8 | −107.3 | 2.11 |
| BMI1 SRX7196721 | SF8628 Neural | 940 / 8593 (10.9%) | 3998 / 85930 (4.7%) | −109.1 | −106.6 | 2.35 |
| CDYL2 SRX8321653 | MCF-7 Breast | 1002 / 8593 (11.7%) | 4429 / 85930 (5.2%) | −108.3 | −105.8 | 2.26 |
| DNA-RNA hybrid SRX20083264 | SH-SY5Y Neural | 440 / 8593 (5.1%) | 1096 / 85930 (1.3%) | −108.1 | −105.6 | 4.01 |
| MEAF6 SRX10606585 | GIST-T1 Digestive tract | 947 / 8593 (11.0%) | 4067 / 85930 (4.7%) | −107.9 | −105.4 | 2.33 |
| SSRP1 SRX3436566 | HT-1080 Bone | 206 / 8593 (2.4%) | 182 / 85930 (0.2%) | −107.8 | −105.2 | 11.32 |
| MECOM SRX23677885 | HNT-34 Blood | 966 / 8593 (11.2%) | 4205 / 85930 (4.9%) | −107.4 | −104.9 | 2.30 |
| Epitope tags SRX392691 | T3M-1 Cl-10 Others | 151 / 8593 (1.8%) | 59 / 85930 (0.1%) | −107.2 | −104.7 | 25.59 |
| RUNX1 SRX2014504 | Jurkat Blood | 1302 / 8593 (15.2%) | 6554 / 85930 (7.6%) | −107.2 | −104.7 | 1.99 |
| FOXA2 SRX4677296 | CFPAC-1 Pancreas | 357 / 8593 (4.2%) | 9435 / 85930 (11.0%) | −106.5 | −104.0 | 0.38 |
| DNA-RNA hybrid SRX20083259 | SH-SY5Y Neural | 485 / 8593 (5.6%) | 1337 / 85930 (1.6%) | −106.4 | −103.9 | 3.63 |
| DNMT3B SRX2862488 | hESC HUES8 Pluripotent stem cell | 272 / 8593 (3.2%) | 396 / 85930 (0.5%) | −106.3 | −103.8 | 6.87 |
| MECOM SRX23677897 | HNT-34 Blood | 1123 / 8593 (13.1%) | 5299 / 85930 (6.2%) | −106.3 | −103.8 | 2.12 |
| ING5 SRX286202 | RKO Digestive tract | 721 / 8593 (8.4%) | 2669 / 85930 (3.1%) | −105.9 | −103.5 | 2.70 |
| ESR1 SRX371476 | MCF-7 Breast | 99 / 8593 (1.2%) | 5083 / 85930 (5.9%) | −105.8 | −103.3 | 0.19 |
| LARP7 SRX2198835 | HeLa Uterus | 1167 / 8593 (13.6%) | 5627 / 85930 (6.5%) | −105.5 | −103.1 | 2.07 |
| YAP1 SRX757325 | H2052 Lung | 418 / 8593 (4.9%) | 10300 / 85930 (12.0%) | −105.4 | −102.9 | 0.41 |
| FOXA1 SRX4815197 | MCF-7 Breast | 398 / 8593 (4.6%) | 9991 / 85930 (11.6%) | −105.0 | −102.5 | 0.40 |
| TP53 SRX396254 | Fibroblasts Others | 496 / 8593 (5.8%) | 1410 / 85930 (1.6%) | −104.9 | −102.4 | 3.52 |
| MEAF6 DRX300417 | 293 Kidney | 829 / 8593 (9.6%) | 3369 / 85930 (3.9%) | −104.3 | −101.8 | 2.46 |
| ESR1 SRX371479 | MCF-7 Breast | 134 / 8593 (1.6%) | 5704 / 85930 (6.6%) | −104.2 | −101.7 | 0.23 |
| FOXA1 SRX176863 | MCF-7 Breast | 186 / 8593 (2.2%) | 6624 / 85930 (7.7%) | −104.0 | −101.5 | 0.28 |
| MECOM SRX23677884 | HNT-34 Blood | 947 / 8593 (11.0%) | 4146 / 85930 (4.8%) | −103.9 | −101.5 | 2.28 |
| PTEN SRX5416007 | SMMC-7721 Liver | 976 / 8593 (11.4%) | 4348 / 85930 (5.1%) | −103.7 | −101.2 | 2.24 |
| Epitope tags SRX392692 | T3M-1 Cl-10 Others | 144 / 8593 (1.7%) | 55 / 85930 (0.1%) | −102.9 | −100.5 | 26.18 |
| GATA3 SRX176864 | MCF-7 Breast | 101 / 8593 (1.2%) | 5035 / 85930 (5.9%) | −102.7 | −100.3 | 0.20 |
| MEAF6 SRX10606584 | GIST-T1 Digestive tract | 852 / 8593 (9.9%) | 3550 / 85930 (4.1%) | −102.4 | −100.0 | 2.40 |
| WDR5 SRX5416008 | SMMC-7721 Liver | 966 / 8593 (11.2%) | 4316 / 85930 (5.0%) | −101.8 | −99.4 | 2.24 |
| FOXA1 SRX1161176 | MCF-7 Breast | 146 / 8593 (1.7%) | 5825 / 85930 (6.8%) | −100.9 | −98.5 | 0.25 |
| FOXA1 SRX3931044 | MCF-7 Breast | 361 / 8593 (4.2%) | 9285 / 85930 (10.8%) | −100.7 | −98.3 | 0.39 |
| MEAF6 DRX234811 | 293 Kidney | 891 / 8593 (10.4%) | 3860 / 85930 (4.5%) | −99.6 | −97.2 | 2.31 |
| ESR1 SRX371468 | MCF-7 Breast | 91 / 8593 (1.1%) | 4743 / 85930 (5.5%) | −99.4 | −97.0 | 0.19 |
| FOXA1 SRX1161173 | MCF-7 Breast | 119 / 8593 (1.4%) | 5282 / 85930 (6.1%) | −99.3 | −96.9 | 0.23 |
| YAP1 SRX757326 | H2052 Lung | 356 / 8593 (4.1%) | 9146 / 85930 (10.6%) | −98.8 | −96.4 | 0.39 |
| ESR2 SRX8272750 | HT-29 Digestive tract | 292 / 8593 (3.4%) | 515 / 85930 (0.6%) | −98.8 | −96.4 | 5.67 |
| TRIM25 SRX1660872 | Breast cancer cells Breast | 898 / 8593 (10.5%) | 3937 / 85930 (4.6%) | −97.9 | −95.5 | 2.28 |
| FOS SRX4192880 | MCF 10A Breast | 286 / 8593 (3.3%) | 8048 / 85930 (9.4%) | −97.9 | −95.5 | 0.36 |
| ESR1 SRX20282961 | MCF-7 Breast | 212 / 8593 (2.5%) | 6864 / 85930 (8.0%) | −97.9 | −95.5 | 0.31 |
| FOXA1 SRX371482 | MCF-7 Breast | 246 / 8593 (2.9%) | 7408 / 85930 (8.6%) | −97.6 | −95.2 | 0.33 |
| RBFOX2 SRX4708034 | Hep G2 Liver | 1017 / 8593 (11.8%) | 4756 / 85930 (5.5%) | −97.6 | −95.2 | 2.14 |
| GATA3 SRX190239 | MCF-7 Breast | 242 / 8593 (2.8%) | 7342 / 85930 (8.5%) | −97.5 | −95.1 | 0.33 |
| FOXA1 SRX371481 | MCF-7 Breast | 174 / 8593 (2.0%) | 6202 / 85930 (7.2%) | −97.2 | −94.8 | 0.28 |
| FOXA1 SRX371483 | MCF-7 Breast | 188 / 8593 (2.2%) | 6426 / 85930 (7.5%) | −96.7 | −94.4 | 0.29 |
| NANOG SRX3288566 | hESC H9 Pluripotent stem cell | 117 / 8593 (1.4%) | 5164 / 85930 (6.0%) | −96.7 | −94.3 | 0.23 |
| MethylCap SRX014767 | NB-4 Blood | 926 / 8593 (10.8%) | 4153 / 85930 (4.8%) | −96.7 | −94.3 | 2.23 |
| ESR1 SRX194572 | MCF-7 Breast | 93 / 8593 (1.1%) | 4687 / 85930 (5.5%) | −96.2 | −93.8 | 0.20 |
| MEAF6 SRX10606586 | GIST-T1 Digestive tract | 663 / 8593 (7.7%) | 2471 / 85930 (2.9%) | −96.0 | −93.6 | 2.68 |
| ESR1 SRX371467 | MCF-7 Breast | 172 / 8593 (2.0%) | 6127 / 85930 (7.1%) | −96.0 | −93.6 | 0.28 |
| DOT1L SRX10606581 | GIST-T1 Digestive tract | 1093 / 8593 (12.7%) | 5327 / 85930 (6.2%) | −95.9 | −93.6 | 2.05 |
| MethylCap SRX014766 | NB-4 Blood | 848 / 8593 (9.9%) | 3648 / 85930 (4.2%) | −95.9 | −93.5 | 2.32 |
| FOXA1 SRX1161175 | MCF-7 Breast | 116 / 8593 (1.3%) | 5103 / 85930 (5.9%) | −95.3 | −92.9 | 0.23 |
| GATA3 SRX5057632 | MCF-7 Breast | 93 / 8593 (1.1%) | 4663 / 85930 (5.4%) | −95.3 | −92.9 | 0.20 |
| ESR1 SRX371470 | ZR-75-1 Breast | 145 / 8593 (1.7%) | 5624 / 85930 (6.5%) | −95.0 | −92.6 | 0.26 |
| FOXA1 SRX371480 | MCF-7 Breast | 103 / 8593 (1.2%) | 4822 / 85930 (5.6%) | −94.1 | −91.7 | 0.21 |
| ESR1 SRX7624157 | MCF-7 Breast | 459 / 8593 (5.3%) | 10461 / 85930 (12.2%) | −94.1 | −91.7 | 0.44 |
| TLE3 SRX4815191 | MCF-7 Breast | 157 / 8593 (1.8%) | 5805 / 85930 (6.8%) | −93.9 | −91.6 | 0.27 |
| CDK9 SRX7366783 | MCF-7 Breast | 143 / 8593 (1.7%) | 76 / 85930 (0.1%) | −92.3 | −90.0 | 18.82 |
| ESR1 SRX371477 | MCF-7 Breast | 69 / 8593 (0.8%) | 4070 / 85930 (4.7%) | −91.7 | −89.3 | 0.17 |
| ESR1 SRX176860 | MCF-7 Breast | 289 / 8593 (3.4%) | 7874 / 85930 (9.2%) | −91.7 | −89.3 | 0.37 |
| ERG SRX063922 | K-562 Blood | 831 / 8593 (9.7%) | 3622 / 85930 (4.2%) | −91.5 | −89.1 | 2.29 |
| RAC1 SRX10365541 | MCF-7 Breast | 78 / 8593 (0.9%) | 4242 / 85930 (4.9%) | −91.0 | −88.7 | 0.18 |
| ZFX SRX7805372 | 293 Kidney | 827 / 8593 (9.6%) | 3602 / 85930 (4.2%) | −91.0 | −88.7 | 2.30 |
| ESR1 SRX194569 | MCF-7 Breast | 178 / 8593 (2.1%) | 6069 / 85930 (7.1%) | −90.9 | −88.6 | 0.29 |
| ESR1 SRX2897220 | Breast cancer cells Breast | 827 / 8593 (9.6%) | 3608 / 85930 (4.2%) | −90.8 | −88.5 | 2.29 |
| Epitope tags SRX8109066 | Gastric cancer cells Digestive tract | 980 / 8593 (11.4%) | 4659 / 85930 (5.4%) | −90.4 | −88.1 | 2.10 |
| ESR1 SRX1531791 | MCF-7 Breast | 165 / 8593 (1.9%) | 5833 / 85930 (6.8%) | −90.4 | −88.0 | 0.28 |
| ESR1 SRX7624156 | MCF-7 Breast | 284 / 8593 (3.3%) | 7750 / 85930 (9.0%) | −90.3 | −87.9 | 0.37 |
| MECOM SRX23677890 | HNT-34 Blood | 943 / 8593 (11.0%) | 4404 / 85930 (5.1%) | −90.2 | −87.9 | 2.14 |
| Epitope tags DRX443510 | 293 Kidney | 757 / 8593 (8.8%) | 3162 / 85930 (3.7%) | −90.0 | −87.7 | 2.39 |
| ETS1 SRX3033231 | HEYA8 Gonad | 183 / 8593 (2.1%) | 185 / 85930 (0.2%) | −89.4 | −87.1 | 9.89 |
| TET2 SRX1427029 | 293 Kidney | 686 / 8593 (8.0%) | 2722 / 85930 (3.2%) | −89.3 | −87.0 | 2.52 |
| GRHL3 SRX2582162 | NHEK Epidermis | 566 / 8593 (6.6%) | 1996 / 85930 (2.3%) | −89.1 | −86.8 | 2.84 |
| ESR1 SRX371471 | ZR-75-1 Breast | 187 / 8593 (2.2%) | 6162 / 85930 (7.2%) | −89.1 | −86.8 | 0.30 |
| RORC SRX5359052 | HCC70 Breast | 681 / 8593 (7.9%) | 2706 / 85930 (3.1%) | −88.4 | −86.1 | 2.52 |
| Epitope tags SRX392690 | T3M-1 Cl-10 Others | 121 / 8593 (1.4%) | 44 / 85930 (0.1%) | −87.7 | −85.4 | 27.50 |
| CDK9 SRX7366781 | MCF-7 Breast | 138 / 8593 (1.6%) | 77 / 85930 (0.1%) | −87.6 | −85.3 | 17.92 |
| FOXA1 SRX8537740 | SUM 44PE Breast | 396 / 8593 (4.6%) | 9301 / 85930 (10.8%) | −87.3 | −85.0 | 0.43 |
| DNA-RNA hybrid SRX20083261 | SH-SY5Y Neural | 333 / 8593 (3.9%) | 782 / 85930 (0.9%) | −86.9 | −84.6 | 4.26 |
| FOXA1 SRX1787653 | MCF-7 Breast | 140 / 8593 (1.6%) | 5283 / 85930 (6.1%) | −86.8 | −84.5 | 0.27 |
| ESR1 SRX10365536 | MCF-7 Breast | 83 / 8593 (1.0%) | 4215 / 85930 (4.9%) | −86.7 | −84.4 | 0.20 |
| NUP98 SRX20440536 | Keratinocytes Epidermis | 272 / 8593 (3.2%) | 519 / 85930 (0.6%) | −86.2 | −83.9 | 5.24 |
| Epitope tags SRX2867680 | 293 Kidney | 1074 / 8593 (12.5%) | 5431 / 85930 (6.3%) | −86.1 | −83.8 | 1.98 |
| RORC SRX5359053 | HCC70 Breast | 654 / 8593 (7.6%) | 2580 / 85930 (3.0%) | −86.0 | −83.7 | 2.53 |
| FOXA1 SRX9419950 | SK-BR-3 Breast | 306 / 8593 (3.6%) | 7929 / 85930 (9.2%) | −85.9 | −83.6 | 0.39 |
| ESR1 SRX20282960 | MCF-7 Breast | 206 / 8593 (2.4%) | 6362 / 85930 (7.4%) | −85.7 | −83.4 | 0.32 |
| NCOA3 SRX8949280 | ZR-75-1 Breast | 212 / 8593 (2.5%) | 6440 / 85930 (7.5%) | −85.2 | −82.9 | 0.33 |
| FOS SRX150517 | MCF 10A Breast | 312 / 8593 (3.6%) | 7986 / 85930 (9.3%) | −85.1 | −82.8 | 0.39 |
| CDK9 SRX10131663 | Bronchial tracheal epithelial cells Lung | 572 / 8593 (6.7%) | 2104 / 85930 (2.4%) | −84.4 | −82.1 | 2.72 |
| RAC1 SRX10365543 | MCF-7 Breast | 87 / 8593 (1.0%) | 4227 / 85930 (4.9%) | −84.4 | −82.1 | 0.21 |
| RBFOX2 SRX4708082 | K-562 Blood | 1210 / 8593 (14.1%) | 6476 / 85930 (7.5%) | −84.3 | −82.1 | 1.87 |
| FOXA1 SRX1161192 | ZR-75-1 Breast | 165 / 8593 (1.9%) | 5637 / 85930 (6.6%) | −84.3 | −82.0 | 0.29 |
| FOXA1 SRX1161187 | ZR-75-1 Breast | 172 / 8593 (2.0%) | 5753 / 85930 (6.7%) | −84.2 | −82.0 | 0.30 |
| Epitope tags SRX8080565 | Mammary gland adenocarcinoma Breast | 73 / 8593 (0.8%) | 3939 / 85930 (4.6%) | −84.1 | −81.9 | 0.19 |
| FOXA1 SRX9419949 | SK-BR-3 Breast | 257 / 8593 (3.0%) | 7106 / 85930 (8.3%) | −83.9 | −81.6 | 0.36 |
| ESR1 SRX4367193 | MCF-7 Breast | 599 / 8593 (7.0%) | 11951 / 85930 (13.9%) | −83.7 | −81.5 | 0.50 |
| ESR1 SRX2943591 | MCF-7 Breast | 115 / 8593 (1.3%) | 4735 / 85930 (5.5%) | −83.6 | −81.4 | 0.24 |
| NABP2 SRX9523535 | HT-1080 Bone | 716 / 8593 (8.3%) | 3018 / 85930 (3.5%) | −83.6 | −81.4 | 2.37 |
| BRPF1 SRX10606575 | GIST-T1 Digestive tract | 351 / 8593 (4.1%) | 906 / 85930 (1.1%) | −82.8 | −80.6 | 3.87 |
| Epitope tags SRX10549778 | K-562 Blood | 581 / 8593 (6.8%) | 2192 / 85930 (2.6%) | −82.1 | −79.8 | 2.65 |
| MECOM SRX23677891 | HNT-34 Blood | 918 / 8593 (10.7%) | 4420 / 85930 (5.1%) | −81.9 | −79.7 | 2.08 |
| ERG SRX063921 | K-562 Blood | 763 / 8593 (8.9%) | 3366 / 85930 (3.9%) | −81.6 | −79.4 | 2.27 |
| NCOA1 SRX036638 | U2OS Bone | 109 / 8593 (1.3%) | 35 / 85930 (0.0%) | −81.6 | −79.4 | 31.14 |
| ESR1 SRX371475 | BT-474 Breast | 82 / 8593 (1.0%) | 4048 / 85930 (4.7%) | −81.6 | −79.4 | 0.20 |
| FOXA1 SRX1161189 | ZR-75-1 Breast | 168 / 8593 (2.0%) | 5584 / 85930 (6.5%) | −81.2 | −79.0 | 0.30 |
| NCOA3 SRX8949281 | ZR-75-1 Breast | 219 / 8593 (2.5%) | 6404 / 85930 (7.5%) | −80.9 | −78.6 | 0.34 |
| FOXA1 SRX1161190 | ZR-75-1 Breast | 165 / 8593 (1.9%) | 5524 / 85930 (6.4%) | −80.9 | −78.6 | 0.30 |
| BRD2 SRX8090642 | Synoviocytes Others | 585 / 8593 (6.8%) | 2238 / 85930 (2.6%) | −80.8 | −78.5 | 2.61 |
| NCOA3 SRX8949279 | ZR-75-1 Breast | 270 / 8593 (3.1%) | 7192 / 85930 (8.4%) | −80.7 | −78.4 | 0.38 |
| ESR1 SRX176861 | MCF-7 Breast | 313 / 8593 (3.6%) | 7837 / 85930 (9.1%) | −80.5 | −78.3 | 0.40 |
| ESR1 SRX20282939 | MCF-7 Breast | 217 / 8593 (2.5%) | 6361 / 85930 (7.4%) | −80.5 | −78.3 | 0.34 |
| KMT2A SRX2323891 | 293 Kidney | 509 / 8593 (5.9%) | 1791 / 85930 (2.1%) | −80.2 | −78.0 | 2.84 |
| FOXA1 SRX1161188 | ZR-75-1 Breast | 127 / 8593 (1.5%) | 4839 / 85930 (5.6%) | −79.9 | −77.7 | 0.26 |
| CHD6 SRX17709200 | C4-2 Prostate | 805 / 8593 (9.4%) | 3685 / 85930 (4.3%) | −79.8 | −77.6 | 2.18 |
| RBFOX2 SRX3323050 | Hep G2 Liver | 787 / 8593 (9.2%) | 3564 / 85930 (4.1%) | −79.8 | −77.6 | 2.21 |
| FOXA1 SRX11222441 | MCF-7 Breast | 139 / 8593 (1.6%) | 5045 / 85930 (5.9%) | −79.8 | −77.6 | 0.28 |
| FOXA1 SRX8537741 | SUM 44PE Breast | 314 / 8593 (3.7%) | 7807 / 85930 (9.1%) | −79.4 | −77.2 | 0.40 |
| Epitope tags SRX7276677 | 293 Kidney | 1348 / 8593 (15.7%) | 7674 / 85930 (8.9%) | −79.3 | −77.1 | 1.76 |
| ING2 SRX286201 | RKO Digestive tract | 721 / 8593 (8.4%) | 3138 / 85930 (3.7%) | −79.1 | −76.9 | 2.30 |
| TET2 SRX2014505 | Jurkat Blood | 1324 / 8593 (15.4%) | 7508 / 85930 (8.7%) | −78.7 | −76.5 | 1.76 |
| JADE3 DRX300415 | 293 Kidney | 759 / 8593 (8.8%) | 3399 / 85930 (4.0%) | −78.7 | −76.5 | 2.23 |
| ESR1 SRX330070 | MCF-7 Breast | 90 / 8593 (1.0%) | 4111 / 85930 (4.8%) | −78.5 | −76.3 | 0.22 |
| ARID1A SRX5089379 | MCF-7 Breast | 185 / 8593 (2.2%) | 5769 / 85930 (6.7%) | −78.3 | −76.1 | 0.32 |
| IRF3 SRX11453864 | Hep G2 Liver | 96 / 8593 (1.1%) | 21 / 85930 (0.0%) | −78.1 | −76.0 | 45.71 |
| FOXA1 SRX1787655 | MCF-7 Breast | 87 / 8593 (1.0%) | 4041 / 85930 (4.7%) | −78.0 | −75.8 | 0.22 |
| KAT7 DRX234808 | 293 Kidney | 398 / 8593 (4.6%) | 1200 / 85930 (1.4%) | −77.9 | −75.7 | 3.32 |
| ESR1 SRX371474 | BT-474 Breast | 78 / 8593 (0.9%) | 3856 / 85930 (4.5%) | −77.7 | −75.5 | 0.20 |
| FOXA1 SRX1161191 | ZR-75-1 Breast | 148 / 8593 (1.7%) | 5134 / 85930 (6.0%) | −77.7 | −75.5 | 0.29 |
| DNA-RNA hybrid SRX14756935 | MDA-MB-436 Breast | 304 / 8593 (3.5%) | 729 / 85930 (0.8%) | −77.6 | −75.4 | 4.17 |
| FOS SRX150476 | MCF 10A Breast | 334 / 8593 (3.9%) | 8025 / 85930 (9.3%) | −77.5 | −75.3 | 0.42 |
| Epitope tags SRX10549777 | K-562 Blood | 1224 / 8593 (14.2%) | 6781 / 85930 (7.9%) | −77.4 | −75.2 | 1.81 |
| DOT1L SRX10606583 | GIST-T1 Digestive tract | 636 / 8593 (7.4%) | 2615 / 85930 (3.0%) | −77.4 | −75.2 | 2.43 |
| TLE3 SRX4815192 | MCF-7 Breast | 170 / 8593 (2.0%) | 5489 / 85930 (6.4%) | −77.3 | −75.2 | 0.31 |
| CBX3 SRX055348 | HCT 116 Digestive tract | 206 / 8593 (2.4%) | 318 / 85930 (0.4%) | −77.3 | −75.1 | 6.48 |
| ARID1A SRX5089376 | MCF-7 Breast | 162 / 8593 (1.9%) | 5353 / 85930 (6.2%) | −77.3 | −75.1 | 0.30 |
| CXXC1 SRX1424886 | SEM Blood | 736 / 8593 (8.6%) | 3279 / 85930 (3.8%) | −77.1 | −74.9 | 2.24 |
| ESR1 SRX10365532 | MCF-7 Breast | 97 / 8593 (1.1%) | 4198 / 85930 (4.9%) | −77.0 | −74.8 | 0.23 |
| ATF3 SRX2207918 | CS1AN Epidermis | 1139 / 8593 (13.3%) | 6156 / 85930 (7.2%) | −76.8 | −74.6 | 1.85 |
| ESR1 SRX3123829 | MCF-7 Breast | 102 / 8593 (1.2%) | 4286 / 85930 (5.0%) | −76.8 | −74.6 | 0.24 |
| HIF1A SRX8180621 | Peripheral blood mononuclear cells Blood | 110 / 8593 (1.3%) | 46 / 85930 (0.1%) | −76.8 | −74.6 | 23.91 |
| FOXA1 SRX3923514 | MCF-7 Breast | 198 / 8593 (2.3%) | 5924 / 85930 (6.9%) | −76.6 | −74.5 | 0.33 |
| SREBF2 SRX5359049 | HCC70 Breast | 607 / 8593 (7.1%) | 2447 / 85930 (2.8%) | −76.6 | −74.5 | 2.48 |
| FOXA2 SRX5504125 | CFPAC-1 Pancreas | 244 / 8593 (2.8%) | 6649 / 85930 (7.7%) | −76.6 | −74.4 | 0.37 |
| CHD6 SRX17709201 | C4-2 Prostate | 769 / 8593 (8.9%) | 3511 / 85930 (4.1%) | −76.6 | −74.4 | 2.19 |
| MEN1 SRX11712604 | K-562 Blood | 701 / 8593 (8.2%) | 3057 / 85930 (3.6%) | −76.4 | −74.3 | 2.29 |
| RBM22 SRX4708083 | K-562 Blood | 473 / 8593 (5.5%) | 1644 / 85930 (1.9%) | −76.0 | −73.8 | 2.88 |
| JUNB SRX8488088 | SUM 229PE Breast | 374 / 8593 (4.4%) | 8533 / 85930 (9.9%) | −75.6 | −73.5 | 0.44 |
| ESR1 SRX20282954 | MCF-7 Breast | 216 / 8593 (2.5%) | 6173 / 85930 (7.2%) | −75.6 | −73.4 | 0.35 |
| Epitope tags SRX14024875 | Mesenchymal stem cells Others | 915 / 8593 (10.6%) | 4553 / 85930 (5.3%) | −75.5 | −73.3 | 2.01 |
| FOXA1 SRX028635 | MCF-7 Breast | 89 / 8593 (1.0%) | 4000 / 85930 (4.7%) | −75.4 | −73.3 | 0.22 |
| CBFB SRX265218 | ME-1 Blood | 742 / 8593 (8.6%) | 3355 / 85930 (3.9%) | −75.3 | −73.2 | 2.21 |
| ESR1 SRX20282972 | MCF-7 Breast | 221 / 8593 (2.6%) | 6237 / 85930 (7.3%) | −75.2 | −73.0 | 0.35 |
| FOXA1 SRX11222437 | MCF-7 Breast | 136 / 8593 (1.6%) | 4845 / 85930 (5.6%) | −75.1 | −73.0 | 0.28 |
| MED1 SRX4937338 | HCT 116 Digestive tract | 706 / 8593 (8.2%) | 3118 / 85930 (3.6%) | −75.1 | −72.9 | 2.26 |
| FOXA1 SRX3931043 | MCF-7 Breast | 199 / 8593 (2.3%) | 5880 / 85930 (6.8%) | −74.8 | −72.7 | 0.34 |
| FOXA1 SRX9419951 | SK-BR-3 Breast | 252 / 8593 (2.9%) | 6706 / 85930 (7.8%) | −74.8 | −72.7 | 0.38 |
| TEAD1 SRX3401272 | MCF-7 Breast | 139 / 8593 (1.6%) | 4881 / 85930 (5.7%) | −74.7 | −72.6 | 0.28 |
| FOXA1 SRX5323843 | MCF-7 Breast | 94 / 8593 (1.1%) | 4072 / 85930 (4.7%) | −74.7 | −72.6 | 0.23 |
| FOXA1 SRX3923517 | MCF-7 Breast | 137 / 8593 (1.6%) | 4838 / 85930 (5.6%) | −74.5 | −72.4 | 0.28 |
| ESR1 SRX20282946 | MCF-7 Breast | 111 / 8593 (1.3%) | 4381 / 85930 (5.1%) | −74.5 | −72.4 | 0.25 |
| FOXA1 SRX15430994 | SK-BR-3 Breast | 193 / 8593 (2.2%) | 5771 / 85930 (6.7%) | −74.5 | −72.4 | 0.33 |
| ZFX SRX7805370 | 293 Kidney | 590 / 8593 (6.9%) | 2381 / 85930 (2.8%) | −74.3 | −72.2 | 2.48 |
| ESR1 SRX1161185 | ZR-75-1 Breast | 90 / 8593 (1.0%) | 3980 / 85930 (4.6%) | −74.1 | −72.0 | 0.23 |
| KMT2A SRX2281249 | SEM Blood | 962 / 8593 (11.2%) | 4925 / 85930 (5.7%) | −74.1 | −72.0 | 1.95 |
| FOXA1 SRX1161174 | MCF-7 Breast | 207 / 8593 (2.4%) | 5978 / 85930 (7.0%) | −74.0 | −71.9 | 0.35 |
| HEXIM1 SRX1177905 | HCT 116 Digestive tract | 921 / 8593 (10.7%) | 4636 / 85930 (5.4%) | −73.9 | −71.8 | 1.99 |
| FOXA1 SRX028634 | MCF-7 Breast | 91 / 8593 (1.1%) | 3994 / 85930 (4.6%) | −73.9 | −71.8 | 0.23 |
| CDK9 SRX20230567 | Ishikawa Uterus | 875 / 8593 (10.2%) | 4310 / 85930 (5.0%) | −73.8 | −71.7 | 2.03 |
| CEBPB SRX150632 | HeLa Uterus | 447 / 8593 (5.2%) | 9477 / 85930 (11.0%) | −73.7 | −71.6 | 0.47 |
| FOXA1 SRX1787652 | MCF-7 Breast | 117 / 8593 (1.4%) | 4463 / 85930 (5.2%) | −73.7 | −71.6 | 0.26 |
| GRHL3 SRX2582161 | NHEK Epidermis | 463 / 8593 (5.4%) | 1625 / 85930 (1.9%) | −73.2 | −71.2 | 2.85 |
| FOXA1 SRX5203303 | MCF-7 Breast | 60 / 8593 (0.7%) | 3360 / 85930 (3.9%) | −73.1 | −71.0 | 0.18 |
| FOXA1 SRX11222442 | MCF-7 Breast | 129 / 8593 (1.5%) | 4648 / 85930 (5.4%) | −72.8 | −70.7 | 0.28 |
| FOXA1 SRX3931054 | MCF-7 Breast | 187 / 8593 (2.2%) | 5605 / 85930 (6.5%) | −72.5 | −70.4 | 0.33 |
| DOT1L SRX10606582 | GIST-T1 Digestive tract | 838 / 8593 (9.8%) | 4079 / 85930 (4.7%) | −72.5 | −70.4 | 2.05 |
| FOXA1 SRX3923516 | MCF-7 Breast | 140 / 8593 (1.6%) | 4819 / 85930 (5.6%) | −72.3 | −70.2 | 0.29 |
| FOXA2 SRX100448 | Hep G2 Liver | 222 / 8593 (2.6%) | 6147 / 85930 (7.2%) | −72.1 | −70.0 | 0.36 |
| FOXA2 SRX6441753 | CFPAC-1 Pancreas | 266 / 8593 (3.1%) | 6814 / 85930 (7.9%) | −72.0 | −69.9 | 0.39 |
| FOXA1 SRX100454 | T-47D Breast | 261 / 8593 (3.0%) | 6737 / 85930 (7.8%) | −71.9 | −69.9 | 0.39 |
| ESR1 SRX2943589 | MCF-7 Breast | 94 / 8593 (1.1%) | 3986 / 85930 (4.6%) | −71.8 | −69.7 | 0.24 |
| VGLL1 SRX24602130 | BT-20 Breast | 203 / 8593 (2.4%) | 5836 / 85930 (6.8%) | −71.7 | −69.6 | 0.35 |
| FOXA1 SRX1787651 | MCF-7 Breast | 112 / 8593 (1.3%) | 4307 / 85930 (5.0%) | −71.5 | −69.4 | 0.26 |
| MethylCap SRX026646 | Acute myeloid leukemia Blood | 327 / 8593 (3.8%) | 902 / 85930 (1.0%) | −71.4 | −69.3 | 3.63 |
| FOXA1 SRX3931055 | MCF-7 Breast | 170 / 8593 (2.0%) | 5289 / 85930 (6.2%) | −71.4 | −69.3 | 0.32 |
| ESR1 SRX10365535 | MCF-7 Breast | 165 / 8593 (1.9%) | 5207 / 85930 (6.1%) | −71.3 | −69.2 | 0.32 |
| CDK9 SRX20230574 | Ishikawa Uterus | 733 / 8593 (8.5%) | 3380 / 85930 (3.9%) | −71.3 | −69.2 | 2.17 |
| AR SRX9469988 | LAPC-4 Prostate | 266 / 8593 (3.1%) | 6780 / 85930 (7.9%) | −71.1 | −69.0 | 0.39 |
| RBFOX2 SRX3323051 | Hep G2 Liver | 750 / 8593 (8.7%) | 3504 / 85930 (4.1%) | −70.9 | −68.8 | 2.14 |
| KAT6A SRX20971024 | Fibroblasts Others | 91 / 8593 (1.1%) | 25 / 85930 (0.0%) | −70.8 | −68.7 | 36.40 |
| ESR1 SRX20282955 | MCF-7 Breast | 214 / 8593 (2.5%) | 5968 / 85930 (6.9%) | −70.6 | −68.6 | 0.36 |
| RBFOX2 SRX3322782 | K-562 Blood | 934 / 8593 (10.9%) | 4820 / 85930 (5.6%) | −70.3 | −68.2 | 1.94 |
| ESR1 SRX2881000 | MCF-7 Breast | 177 / 8593 (2.1%) | 5370 / 85930 (6.2%) | −70.3 | −68.2 | 0.33 |
| ESR1 SRX330067 | MCF-7 Breast | 184 / 8593 (2.1%) | 5477 / 85930 (6.4%) | −70.2 | −68.2 | 0.34 |
| JUN SRX11051031 | hTERT RPE-1 Neural | 670 / 8593 (7.8%) | 12276 / 85930 (14.3%) | −70.2 | −68.1 | 0.55 |
| ESR1 SRX1012632 | MCF-7 Breast | 98 / 8593 (1.1%) | 4007 / 85930 (4.7%) | −70.0 | −68.0 | 0.24 |
| DNA-RNA hybrid SRX15232261 | MDA-MB-436 Breast | 162 / 8593 (1.9%) | 203 / 85930 (0.2%) | −70.0 | −68.0 | 7.98 |
| EP300 SRX176885 | MCF-7 Breast | 99 / 8593 (1.2%) | 4022 / 85930 (4.7%) | −70.0 | −67.9 | 0.25 |
| CTCF SRX12008351 | MCF 10A Breast | 1430 / 8593 (16.6%) | 8633 / 85930 (10.0%) | −69.9 | −67.8 | 1.66 |
| PHF6 SRX11508321 | G-401 Kidney | 754 / 8593 (8.8%) | 3562 / 85930 (4.1%) | −69.6 | −67.6 | 2.12 |
| Crotonyllysine SRX19488269 | GSC23 Neural | 601 / 8593 (7.0%) | 2537 / 85930 (3.0%) | −69.6 | −67.5 | 2.37 |
| ESR1 SRX330069 | MCF-7 Breast | 123 / 8593 (1.4%) | 4427 / 85930 (5.2%) | −69.2 | −67.2 | 0.28 |
| NR2F2 SRX190293 | MCF-7 Breast | 218 / 8593 (2.5%) | 5977 / 85930 (7.0%) | −69.2 | −67.2 | 0.36 |
| ESR1 SRX10365533 | MCF-7 Breast | 93 / 8593 (1.1%) | 3881 / 85930 (4.5%) | −68.9 | −66.9 | 0.24 |
| PAF1 SRX1873455 | SEM Blood | 363 / 8593 (4.2%) | 1121 / 85930 (1.3%) | −68.8 | −66.8 | 3.24 |
| G3BP1 SRX24196609 | KGN Gonad | 807 / 8593 (9.4%) | 3950 / 85930 (4.6%) | −68.7 | −66.7 | 2.04 |
| ESR1 SRX1469949 | MCF-7 Breast | 116 / 8593 (1.3%) | 4286 / 85930 (5.0%) | −68.7 | −66.6 | 0.27 |
| ESR1 SRX330068 | MCF-7 Breast | 94 / 8593 (1.1%) | 3893 / 85930 (4.5%) | −68.7 | −66.6 | 0.24 |
| EP300 SRX1012643 | MCF-7 Breast | 68 / 8593 (0.8%) | 3392 / 85930 (3.9%) | −68.6 | −66.6 | 0.20 |
| BCOR SRX10184505 | KG-1 Blood | 477 / 8593 (5.6%) | 1778 / 85930 (2.1%) | −68.4 | −66.4 | 2.68 |
| FOXA1 SRX3923518 | MCF-7 Breast | 142 / 8593 (1.7%) | 4726 / 85930 (5.5%) | −68.4 | −66.3 | 0.30 |
| HDAC1 SRX20517420 | Keratinocytes Epidermis | 813 / 8593 (9.5%) | 4003 / 85930 (4.7%) | −68.3 | −66.3 | 2.03 |
| FOXA1 SRX5124035 | 22Rv1 Prostate | 267 / 8593 (3.1%) | 6685 / 85930 (7.8%) | −68.2 | −66.2 | 0.40 |
| YAP1 SRX5718140 | 293 Kidney | 349 / 8593 (4.1%) | 7879 / 85930 (9.2%) | −68.2 | −66.1 | 0.44 |
| RBFOX2 SRX3322781 | K-562 Blood | 982 / 8593 (11.4%) | 5230 / 85930 (6.1%) | −68.2 | −66.1 | 1.88 |
| FOS SRX3322636 | MCF-7 Breast | 132 / 8593 (1.5%) | 4545 / 85930 (5.3%) | −68.0 | −66.0 | 0.29 |
| FOXA1 SRX5203307 | MCF-7 Breast | 56 / 8593 (0.7%) | 3130 / 85930 (3.6%) | −68.0 | −65.9 | 0.18 |
| ESR1 SRX1531796 | MCF-7 Breast | 106 / 8593 (1.2%) | 4085 / 85930 (4.8%) | −67.9 | −65.9 | 0.26 |
| Epitope tags SRX15725652 | 293 Kidney | 900 / 8593 (10.5%) | 4642 / 85930 (5.4%) | −67.7 | −65.6 | 1.94 |
| FOXA1 SRX15430993 | SK-BR-3 Breast | 186 / 8593 (2.2%) | 5419 / 85930 (6.3%) | −67.6 | −65.6 | 0.34 |
| ESR1 SRX3110725 | MCF-7 Breast | 189 / 8593 (2.2%) | 5466 / 85930 (6.4%) | −67.6 | −65.6 | 0.35 |
| STAT1 SRX23678708 | K-562 Blood | 742 / 8593 (8.6%) | 3525 / 85930 (4.1%) | −67.6 | −65.5 | 2.10 |
| AFF4 SRX7615734 | MCF-7 Breast | 227 / 8593 (2.6%) | 466 / 85930 (0.5%) | −67.5 | −65.5 | 4.87 |
| DNA-RNA hybrid SRX15232266 | MDA-MB-436 Breast | 133 / 8593 (1.5%) | 126 / 85930 (0.1%) | −67.4 | −65.4 | 10.56 |
| EP300 SRX1012648 | MCF-7 Breast | 96 / 8593 (1.1%) | 3886 / 85930 (4.5%) | −67.4 | −65.4 | 0.25 |
| CDK9 SRX20230570 | Ishikawa Uterus | 822 / 8593 (9.6%) | 4094 / 85930 (4.8%) | −67.3 | −65.3 | 2.01 |
| MED1 SRX4937342 | HCT 116 Digestive tract | 648 / 8593 (7.5%) | 2892 / 85930 (3.4%) | −67.3 | −65.3 | 2.24 |
| FOXA2 SRX3230382 | Hep G2 Liver | 290 / 8593 (3.4%) | 6989 / 85930 (8.1%) | −67.2 | −65.1 | 0.41 |
| ARID1A SRX5089385 | MCF-7 Breast | 154 / 8593 (1.8%) | 4882 / 85930 (5.7%) | −67.1 | −65.1 | 0.32 |
| ESR1 SRX10365534 | MCF-7 Breast | 56 / 8593 (0.7%) | 3102 / 85930 (3.6%) | −67.0 | −65.0 | 0.18 |
| FOXA1 SRX100506 | Hep G2 Liver | 281 / 8593 (3.3%) | 6842 / 85930 (8.0%) | −66.8 | −64.8 | 0.41 |
| FOXA1 SRX3923519 | MCF-7 Breast | 128 / 8593 (1.5%) | 4434 / 85930 (5.2%) | −66.7 | −64.7 | 0.29 |
| FOXA1 SRX3923533 | ZR-75-1 Breast | 227 / 8593 (2.6%) | 6023 / 85930 (7.0%) | −66.7 | −64.6 | 0.38 |
| INTS3 SRX3640569 | HeLa Uterus | 621 / 8593 (7.2%) | 2725 / 85930 (3.2%) | −66.6 | −64.6 | 2.28 |
| ESR1 SRX2912055 | MCF-7 Breast | 78 / 8593 (0.9%) | 3526 / 85930 (4.1%) | −66.6 | −64.6 | 0.22 |
| ESR1 SRX1012629 | MCF-7 Breast | 131 / 8593 (1.5%) | 4477 / 85930 (5.2%) | −66.5 | −64.5 | 0.29 |
| Epitope tags SRX8080558 | Mammary gland adenocarcinoma Breast | 72 / 8593 (0.8%) | 3404 / 85930 (4.0%) | −66.4 | −64.4 | 0.21 |
| FOXA1 SRX6878603 | LNCAP Prostate | 231 / 8593 (2.7%) | 6072 / 85930 (7.1%) | −66.3 | −64.3 | 0.38 |
| FOXA1 SRX9419952 | SK-BR-3 Breast | 200 / 8593 (2.3%) | 5595 / 85930 (6.5%) | −66.3 | −64.3 | 0.36 |
| PGR SRX1012655 | MCF-7 Breast | 131 / 8593 (1.5%) | 4467 / 85930 (5.2%) | −66.2 | −64.2 | 0.29 |
| LEO1 SRX15147190 | DLD-1 Digestive tract | 426 / 8593 (5.0%) | 1512 / 85930 (1.8%) | −66.2 | −64.2 | 2.82 |
| FOXA1 SRX11222438 | MCF-7 Breast | 110 / 8593 (1.3%) | 4100 / 85930 (4.8%) | −66.1 | −64.1 | 0.27 |
| FOS SRX4192879 | MCF 10A Breast | 243 / 8593 (2.8%) | 6248 / 85930 (7.3%) | −66.0 | −64.1 | 0.39 |
| FOXA1 SRX3923529 | ZR-75-1 Breast | 196 / 8593 (2.3%) | 5523 / 85930 (6.4%) | −66.0 | −64.0 | 0.35 |
| ESR1 SRX4451213 | MCF-7 Breast | 218 / 8593 (2.5%) | 5859 / 85930 (6.8%) | −65.9 | −63.9 | 0.37 |
| FOXA1 SRX3931033 | MCF-7 Breast | 134 / 8593 (1.6%) | 4507 / 85930 (5.2%) | −65.8 | −63.8 | 0.30 |
| CTCF SRX12008350 | MCF 10A Breast | 1446 / 8593 (16.8%) | 8913 / 85930 (10.4%) | −65.7 | −63.8 | 1.62 |
| Epitope tags SRX20570808 | Keratinocytes Epidermis | 436 / 8593 (5.1%) | 1578 / 85930 (1.8%) | −65.6 | −63.7 | 2.76 |
| FOXA1 SRX5124036 | 22Rv1 Prostate | 221 / 8593 (2.6%) | 5894 / 85930 (6.9%) | −65.6 | −63.6 | 0.37 |
| FOXA1 SRX1787654 | MCF-7 Breast | 76 / 8593 (0.9%) | 3455 / 85930 (4.0%) | −65.5 | −63.6 | 0.22 |
| FOXA1 SRX5203294 | MCF-7 Breast | 58 / 8593 (0.7%) | 3102 / 85930 (3.6%) | −65.5 | −63.5 | 0.19 |
| ESR1 SRX2881002 | MCF-7 Breast | 203 / 8593 (2.4%) | 5613 / 85930 (6.5%) | −65.5 | −63.5 | 0.36 |
| ESR1 SRX20282973 | MCF-7 Breast | 260 / 8593 (3.0%) | 6474 / 85930 (7.5%) | −65.3 | −63.3 | 0.40 |
| ESR1 SRX20282940 | MCF-7 Breast | 233 / 8593 (2.7%) | 6068 / 85930 (7.1%) | −65.3 | −63.3 | 0.38 |
| FOXA1 SRX8083098 | CAMA-1 Breast | 174 / 8593 (2.0%) | 5142 / 85930 (6.0%) | −65.2 | −63.2 | 0.34 |
| GATA3 SRX6712581 | MCF-7 Breast | 179 / 8593 (2.1%) | 5222 / 85930 (6.1%) | −65.1 | −63.2 | 0.34 |
| FOXA1 SRX5323845 | MCF-7 Breast | 74 / 8593 (0.9%) | 3404 / 85930 (4.0%) | −65.1 | −63.1 | 0.22 |
| MED1 SRX4937336 | HCT 116 Digestive tract | 766 / 8593 (8.9%) | 3752 / 85930 (4.4%) | −65.1 | −63.1 | 2.04 |
| Epitope tags SRX4192708 | MDA-MB-231 Breast | 502 / 8593 (5.8%) | 1990 / 85930 (2.3%) | −65.0 | −63.0 | 2.52 |
| JUNB SRX10119396 | MDA-MB-231 Breast | 222 / 8593 (2.6%) | 5885 / 85930 (6.8%) | −64.9 | −63.0 | 0.38 |
| FOXA1 SRX3923515 | MCF-7 Breast | 118 / 8593 (1.4%) | 4198 / 85930 (4.9%) | −64.9 | −62.9 | 0.28 |
| ESR1 SRX4367192 | MCF-7 Breast | 432 / 8593 (5.0%) | 8894 / 85930 (10.4%) | −64.8 | −62.8 | 0.49 |
| BRD2 SRX8090652 | Synoviocytes Others | 581 / 8593 (6.8%) | 2500 / 85930 (2.9%) | −64.7 | −62.7 | 2.32 |
| PGR SRX6068069 | Endometrium Uterus | 882 / 8593 (10.3%) | 4593 / 85930 (5.3%) | −64.7 | −62.7 | 1.92 |
| MYOCD SRX5598318 | A549 Lung | 822 / 8593 (9.6%) | 4162 / 85930 (4.8%) | −64.6 | −62.6 | 1.98 |
| FOXA1 SRX825395 | CFPAC-1 Pancreas | 204 / 8593 (2.4%) | 5592 / 85930 (6.5%) | −64.6 | −62.6 | 0.36 |
| RBM22 SRX3322379 | Hep G2 Liver | 412 / 8593 (4.8%) | 1454 / 85930 (1.7%) | −64.5 | −62.6 | 2.83 |
| ESR1 SRX20282953 | MCF-7 Breast | 175 / 8593 (2.0%) | 5136 / 85930 (6.0%) | −64.5 | −62.5 | 0.34 |
| Epitope tags SRX2255894 | 293 Kidney | 644 / 8593 (7.5%) | 2927 / 85930 (3.4%) | −64.3 | −62.4 | 2.20 |
| FOXA1 SRX1389381 | CFPAC-1 Pancreas | 191 / 8593 (2.2%) | 5380 / 85930 (6.3%) | −64.3 | −62.3 | 0.36 |
| FOXA1 SRX5323846 | MCF-7 Breast | 77 / 8593 (0.9%) | 3437 / 85930 (4.0%) | −64.2 | −62.3 | 0.22 |
| Epitope tags SRX7276675 | 293 Kidney | 1158 / 8593 (13.5%) | 6686 / 85930 (7.8%) | −64.2 | −62.2 | 1.73 |
| ESR1 SRX10365558 | MCF-7 Breast | 145 / 8593 (1.7%) | 4633 / 85930 (5.4%) | −64.1 | −62.2 | 0.31 |
| FOXA1 SRX1161203 | T-47D Breast | 156 / 8593 (1.8%) | 4812 / 85930 (5.6%) | −64.1 | −62.1 | 0.32 |
| ESR1 SRX4451212 | MCF-7 Breast | 206 / 8593 (2.4%) | 5605 / 85930 (6.5%) | −64.1 | −62.1 | 0.37 |
| Epitope tags SRX15426925 | Keratinocytes Epidermis | 282 / 8593 (3.3%) | 753 / 85930 (0.9%) | −64.0 | −62.0 | 3.75 |
| FOXA1 SRX3923511 | MCF-7 Breast | 80 / 8593 (0.9%) | 3485 / 85930 (4.1%) | −64.0 | −62.0 | 0.23 |
| ESR1 SRX8537722 | MCF-7 Breast | 204 / 8593 (2.4%) | 5572 / 85930 (6.5%) | −63.9 | −62.0 | 0.37 |
| CHD7 SRX3581507 | iPS cells Pluripotent stem cell | 177 / 8593 (2.1%) | 5142 / 85930 (6.0%) | −63.8 | −61.9 | 0.34 |
| NR3C1 SRX19024866 | MCF-7 Breast | 72 / 8593 (0.8%) | 3322 / 85930 (3.9%) | −63.7 | −61.7 | 0.22 |
| AFF1 SRX2281250 | SEM Blood | 465 / 8593 (5.4%) | 1785 / 85930 (2.1%) | −63.6 | −61.7 | 2.61 |
| ESR1 SRX1161186 | ZR-75-1 Breast | 67 / 8593 (0.8%) | 3224 / 85930 (3.8%) | −63.5 | −61.6 | 0.21 |
| GATA1 SRX4172744 | HCT 116 Digestive tract | 727 / 8593 (8.5%) | 3515 / 85930 (4.1%) | −63.5 | −61.5 | 2.07 |
| ESR1 SRX1012630 | MCF-7 Breast | 79 / 8593 (0.9%) | 3453 / 85930 (4.0%) | −63.5 | −61.5 | 0.23 |
| CSTF2 SRX10722980 | U2OS Bone | 376 / 8593 (4.4%) | 1262 / 85930 (1.5%) | −63.4 | −61.5 | 2.98 |
| CDK9 SRX7366779 | MCF-7 Breast | 103 / 8593 (1.2%) | 63 / 85930 (0.1%) | −63.4 | −61.5 | 16.35 |
| FOXA1 SRX6441749 | CFPAC-1 Pancreas | 203 / 8593 (2.4%) | 5537 / 85930 (6.4%) | −63.4 | −61.4 | 0.37 |
| FOXA1 SRX2017929 | LNCAP Prostate | 286 / 8593 (3.3%) | 6777 / 85930 (7.9%) | −63.2 | −61.3 | 0.42 |
| KAT6A DRX366108 | 293 Kidney | 824 / 8593 (9.6%) | 4210 / 85930 (4.9%) | −63.2 | −61.3 | 1.96 |
| Epitope tags SRX8030771 | 293 Kidney | 779 / 8593 (9.1%) | 3890 / 85930 (4.5%) | −63.2 | −61.2 | 2.00 |
| GATA3 SRX5457550 | MCF-7 Breast | 248 / 8593 (2.9%) | 6208 / 85930 (7.2%) | −63.1 | −61.2 | 0.40 |
| RELA SRX2207673 | HUVEC Cardiovascular | 749 / 8593 (8.7%) | 12921 / 85930 (15.0%) | −62.9 | −61.0 | 0.58 |
| FOXA1 SRX6441747 | CFPAC-1 Pancreas | 206 / 8593 (2.4%) | 5563 / 85930 (6.5%) | −62.9 | −60.9 | 0.37 |
| EP300 SRX1012644 | MCF-7 Breast | 96 / 8593 (1.1%) | 3744 / 85930 (4.4%) | −62.8 | −60.9 | 0.26 |
| KMT2A SRX1293531 | MV-4-11 Blood | 1208 / 8593 (14.1%) | 7122 / 85930 (8.3%) | −62.8 | −60.9 | 1.70 |
| JUNB SRX10119386 | MCF 10A Breast | 197 / 8593 (2.3%) | 5419 / 85930 (6.3%) | −62.7 | −60.8 | 0.36 |
| ARID1A SRX5089382 | MCF-7 Breast | 153 / 8593 (1.8%) | 4711 / 85930 (5.5%) | −62.6 | −60.7 | 0.32 |
| FOXA1 SRX1447317 | MCF-7 Breast | 141 / 8593 (1.6%) | 4510 / 85930 (5.2%) | −62.4 | −60.5 | 0.31 |
| ESR1 SRX2901942 | Ishikawa Uterus | 559 / 8593 (6.5%) | 2406 / 85930 (2.8%) | −62.2 | −60.2 | 2.32 |
| Epitope tags SRX15725650 | 293 Kidney | 785 / 8593 (9.1%) | 3961 / 85930 (4.6%) | −62.0 | −60.1 | 1.98 |
| ESR1 SRX8537723 | MCF-7 Breast | 180 / 8593 (2.1%) | 5122 / 85930 (6.0%) | −61.9 | −60.0 | 0.35 |
| FOXA2 SRX6441752 | CFPAC-1 Pancreas | 237 / 8593 (2.8%) | 6000 / 85930 (7.0%) | −61.9 | −60.0 | 0.40 |
| JUN SRX11051032 | hTERT RPE-1 Neural | 690 / 8593 (8.0%) | 12129 / 85930 (14.1%) | −61.9 | −60.0 | 0.57 |
| BCOR SRX10184493 | K-562 Blood | 1035 / 8593 (12.0%) | 5817 / 85930 (6.8%) | −61.8 | −59.9 | 1.78 |
| ARID1A SRX5089391 | MCF-7 Breast | 122 / 8593 (1.4%) | 4164 / 85930 (4.8%) | −61.7 | −59.8 | 0.29 |
| FOXA2 SRX11650948 | hESC derived pancreatic cells Pluripotent stem cell | 190 / 8593 (2.2%) | 5273 / 85930 (6.1%) | −61.7 | −59.7 | 0.36 |
| KAT6A DRX366109 | 293 Kidney | 980 / 8593 (11.4%) | 5410 / 85930 (6.3%) | −61.5 | −59.6 | 1.81 |
| ESR1 SRX4451199 | MCF-7 Breast | 253 / 8593 (2.9%) | 636 / 85930 (0.7%) | −61.5 | −59.5 | 3.98 |
| DNMT3B SRX2862487 | hESC HUES8 Pluripotent stem cell | 142 / 8593 (1.7%) | 178 / 85930 (0.2%) | −61.4 | −59.5 | 7.98 |
| WAS SRX5371250 | GM11518 Blood | 524 / 8593 (6.1%) | 2193 / 85930 (2.6%) | −61.4 | −59.5 | 2.39 |
| FOXA2 SRX6441750 | CFPAC-1 Pancreas | 200 / 8593 (2.3%) | 5415 / 85930 (6.3%) | −61.3 | −59.4 | 0.37 |
| FOXA2 SRX11650944 | hESC derived pancreatic cells Pluripotent stem cell | 192 / 8593 (2.2%) | 5287 / 85930 (6.2%) | −61.3 | −59.4 | 0.36 |
| ESR1 SRX1469951 | MCF-7 Breast | 116 / 8593 (1.3%) | 4049 / 85930 (4.7%) | −61.2 | −59.3 | 0.29 |
| ESR1 SRX20282959 | MCF-7 Breast | 91 / 8593 (1.1%) | 3607 / 85930 (4.2%) | −61.2 | −59.3 | 0.25 |
| RBM22 SRX4708035 | Hep G2 Liver | 457 / 8593 (5.3%) | 1773 / 85930 (2.1%) | −61.2 | −59.3 | 2.58 |
| NCOA3 SRX4663589 | MCF-7 Breast | 61 / 8593 (0.7%) | 3032 / 85930 (3.5%) | −61.2 | −59.2 | 0.20 |
| FOXA1 SRX3931032 | MCF-7 Breast | 128 / 8593 (1.5%) | 4246 / 85930 (4.9%) | −61.1 | −59.2 | 0.30 |
| VGLL1 SRX18013277 | FULVR Breast | 91 / 8593 (1.1%) | 3600 / 85930 (4.2%) | −61.1 | −59.2 | 0.25 |
| FOXA1 SRX8083099 | CAMA-1 Breast | 208 / 8593 (2.4%) | 5529 / 85930 (6.4%) | −61.1 | −59.2 | 0.38 |
| CDK9 SRX20230573 | Ishikawa Uterus | 1035 / 8593 (12.0%) | 5842 / 85930 (6.8%) | −61.1 | −59.2 | 1.77 |
| RTF1 SRX15147196 | DLD-1 Digestive tract | 321 / 8593 (3.7%) | 990 / 85930 (1.2%) | −60.9 | −59.0 | 3.24 |
| CBX3 SRX055346 | HCT 116 Digestive tract | 132 / 8593 (1.5%) | 149 / 85930 (0.2%) | −60.9 | −58.9 | 8.86 |
| Epitope tags SRX10715360 | HCB1 Blood | 535 / 8593 (6.2%) | 2278 / 85930 (2.7%) | −60.7 | −58.8 | 2.35 |
| SETD1A SRX23734379 | MOLM-13 Blood | 585 / 8593 (6.8%) | 2607 / 85930 (3.0%) | −60.7 | −58.8 | 2.24 |
| KMT2A SRX8151120 | VDH-15 Others | 991 / 8593 (11.5%) | 5520 / 85930 (6.4%) | −60.6 | −58.7 | 1.80 |
| CDK9 SRX10131662 | Bronchial tracheal epithelial cells Lung | 291 / 8593 (3.4%) | 835 / 85930 (1.0%) | −60.6 | −58.7 | 3.49 |
| CSTF2 SRX10448647 | HeLa Uterus | 465 / 8593 (5.4%) | 1838 / 85930 (2.1%) | −60.5 | −58.6 | 2.53 |
| GATA3 SRX190194 | SK-N-SH Neural | 510 / 8593 (5.9%) | 9745 / 85930 (11.3%) | −60.5 | −58.6 | 0.52 |
| ESR1 SRX5323873 | MCF-7 Breast | 272 / 8593 (3.2%) | 6456 / 85930 (7.5%) | −60.4 | −58.5 | 0.42 |
| ESR1 SRX1012633 | MCF-7 Breast | 116 / 8593 (1.3%) | 4016 / 85930 (4.7%) | −60.3 | −58.4 | 0.29 |
| Epitope tags SRX15426922 | Keratinocytes Epidermis | 357 / 8593 (4.2%) | 1196 / 85930 (1.4%) | −60.3 | −58.4 | 2.98 |
| FOXA1 SRX219284 | LNCAP Prostate | 299 / 8593 (3.5%) | 6843 / 85930 (8.0%) | −60.2 | −58.3 | 0.44 |
| CTCF SRX13551281 | Adipose stem cells Adipocyte | 1441 / 8593 (16.8%) | 9086 / 85930 (10.6%) | −60.1 | −58.2 | 1.59 |
| Crotonyllysine SRX12306536 | Polycystic kidney Kidney | 737 / 8593 (8.6%) | 3668 / 85930 (4.3%) | −60.1 | −58.2 | 2.01 |
| ESR1 SRX1012625 | MCF-7 Breast | 119 / 8593 (1.4%) | 4059 / 85930 (4.7%) | −60.0 | −58.1 | 0.29 |
| KDM6A SRX15826236 | MCF-7 Breast | 69 / 8593 (0.8%) | 3153 / 85930 (3.7%) | −59.9 | −58.0 | 0.22 |
| CNOT3 SRX886388 | Colorectal carcinoma Digestive tract | 925 / 8593 (10.8%) | 5046 / 85930 (5.9%) | −59.8 | −57.9 | 1.83 |
| ESR1 SRX2513517 | MCF-7 Breast | 154 / 8593 (1.8%) | 4630 / 85930 (5.4%) | −59.8 | −57.9 | 0.33 |
| KAT7 DRX300414 | 293 Kidney | 291 / 8593 (3.4%) | 847 / 85930 (1.0%) | −59.5 | −57.7 | 3.44 |
| KMT2A SRX8151116 | VDH-15 Others | 810 / 8593 (9.4%) | 4213 / 85930 (4.9%) | −59.4 | −57.5 | 1.92 |
| ESR1 SRX5323877 | MCF-7 Breast | 175 / 8593 (2.0%) | 4952 / 85930 (5.8%) | −59.3 | −57.4 | 0.35 |
| ARID1A SRX5089388 | MCF-7 Breast | 117 / 8593 (1.4%) | 3997 / 85930 (4.7%) | −59.3 | −57.4 | 0.29 |
| ESR1 SRX792933 | LY2 Breast | 182 / 8593 (2.1%) | 5057 / 85930 (5.9%) | −59.2 | −57.3 | 0.36 |
| ZEB1 SRX13298925 | MCF-7 Breast | 142 / 8593 (1.7%) | 4411 / 85930 (5.1%) | −59.1 | −57.3 | 0.32 |
| MAU2 SRX11120893 | MCF-7 Breast | 93 / 8593 (1.1%) | 3571 / 85930 (4.2%) | −59.1 | −57.2 | 0.26 |
| ZNF711 SRX7805363 | 293 Kidney | 720 / 8593 (8.4%) | 3572 / 85930 (4.2%) | −59.0 | −57.2 | 2.02 |
| JUNB SRX4192882 | MCF 10A Breast | 180 / 8593 (2.1%) | 5022 / 85930 (5.8%) | −59.0 | −57.2 | 0.36 |
| NANOG SRX5286327 | ES cells Pluripotent stem cell | 162 / 8593 (1.9%) | 4726 / 85930 (5.5%) | −58.9 | −57.0 | 0.34 |
| FOXA1 SRX1161205 | T-47D Breast | 125 / 8593 (1.5%) | 4119 / 85930 (4.8%) | −58.9 | −57.0 | 0.30 |
| BRD4 SRX1272808 | COLO 741 Digestive tract | 606 / 8593 (7.1%) | 2787 / 85930 (3.2%) | −58.8 | −56.9 | 2.17 |
| Epitope tags SRX4892334 | 293 Kidney | 1121 / 8593 (13.0%) | 6580 / 85930 (7.7%) | −58.8 | −56.9 | 1.70 |
| FOXA1 SRX9604647 | LNCAP Prostate | 332 / 8593 (3.9%) | 7252 / 85930 (8.4%) | −58.7 | −56.9 | 0.46 |
| FOXA1 SRX3931056 | MCF-7 Breast | 135 / 8593 (1.6%) | 4283 / 85930 (5.0%) | −58.7 | −56.9 | 0.32 |
| JUND SRX150408 | HeLa Uterus | 200 / 8593 (2.3%) | 5321 / 85930 (6.2%) | −58.7 | −56.8 | 0.38 |
| Epitope tags SRX3657345 | 293 Kidney | 1118 / 8593 (13.0%) | 6563 / 85930 (7.6%) | −58.6 | −56.8 | 1.70 |
| JADE3 DRX234809 | 293 Kidney | 470 / 8593 (5.5%) | 1903 / 85930 (2.2%) | −58.6 | −56.7 | 2.47 |
| AR SRX1067071 | LHSAR Prostate | 427 / 8593 (5.0%) | 8552 / 85930 (10.0%) | −58.5 | −56.7 | 0.50 |
| MYC SRX13134693 | 293 Kidney | 618 / 8593 (7.2%) | 2877 / 85930 (3.3%) | −58.4 | −56.5 | 2.15 |
| ESR1 SRX20282938 | MCF-7 Breast | 187 / 8593 (2.2%) | 5104 / 85930 (5.9%) | −58.4 | −56.5 | 0.37 |
| FOXA1 SRX1447316 | MCF-7 Breast | 101 / 8593 (1.2%) | 3691 / 85930 (4.3%) | −58.4 | −56.5 | 0.27 |
| MED1 SRX5236337 | HUVEC Cardiovascular | 263 / 8593 (3.1%) | 716 / 85930 (0.8%) | −58.4 | −56.5 | 3.67 |
| ESR1 SRX3110723 | MCF-7 Breast | 129 / 8593 (1.5%) | 4172 / 85930 (4.9%) | −58.3 | −56.5 | 0.31 |
| PAF1 SRX15147186 | DLD-1 Digestive tract | 378 / 8593 (4.4%) | 1345 / 85930 (1.6%) | −58.2 | −56.4 | 2.81 |
| KMT2A SRX8151118 | VDH-15 Others | 942 / 8593 (11.0%) | 5233 / 85930 (6.1%) | −57.9 | −56.1 | 1.80 |
| BCOR SRX10184500 | Acute myeloid leukemia Blood | 765 / 8593 (8.9%) | 3927 / 85930 (4.6%) | −57.8 | −56.0 | 1.95 |
| ESR1 SRX2513521 | MCF-7 Breast | 111 / 8593 (1.3%) | 3845 / 85930 (4.5%) | −57.8 | −55.9 | 0.29 |
| CDK9 SRX20230572 | Ishikawa Uterus | 801 / 8593 (9.3%) | 4194 / 85930 (4.9%) | −57.6 | −55.8 | 1.91 |
| FOXA1 SRX6878604 | LNCAP Prostate | 185 / 8593 (2.2%) | 5045 / 85930 (5.9%) | −57.6 | −55.8 | 0.37 |
| NR3C1 SRX19024870 | MCF-7 Breast | 78 / 8593 (0.9%) | 3251 / 85930 (3.8%) | −57.6 | −55.8 | 0.24 |
| ERG SRX063918 | MCF-7 Breast | 695 / 8593 (8.1%) | 3434 / 85930 (4.0%) | −57.6 | −55.7 | 2.02 |
| NKX2-1 SRX2164786 | A549 Lung | 363 / 8593 (4.2%) | 7631 / 85930 (8.9%) | −57.5 | −55.7 | 0.48 |
| MED1 SRX4937340 | HCT 116 Digestive tract | 748 / 8593 (8.7%) | 3812 / 85930 (4.4%) | −57.5 | −55.7 | 1.96 |
| ESR1 SRX2897217 | Breast cancer cells Breast | 455 / 8593 (5.3%) | 1825 / 85930 (2.1%) | −57.5 | −55.6 | 2.49 |
| EP300 SRX150579 | HeLa Uterus | 157 / 8593 (1.8%) | 4594 / 85930 (5.3%) | −57.3 | −55.5 | 0.34 |
| Epitope tags SRX14024876 | Mesenchymal stem cells Others | 1049 / 8593 (12.2%) | 6072 / 85930 (7.1%) | −57.2 | −55.4 | 1.73 |
| FOXA1 SRX3923508 | MCF-7 Breast | 75 / 8593 (0.9%) | 3187 / 85930 (3.7%) | −57.2 | −55.4 | 0.24 |
| FOXA1 SRX3923530 | ZR-75-1 Breast | 153 / 8593 (1.8%) | 4527 / 85930 (5.3%) | −57.2 | −55.4 | 0.34 |
| SUPT6H SRX15147167 | DLD-1 Digestive tract | 618 / 8593 (7.2%) | 2908 / 85930 (3.4%) | −57.2 | −55.3 | 2.13 |
| FOXA1 SRX219285 | LNCAP Prostate | 212 / 8593 (2.5%) | 5445 / 85930 (6.3%) | −57.2 | −55.3 | 0.39 |
| FOXA1 SRX3923528 | ZR-75-1 Breast | 159 / 8593 (1.9%) | 4619 / 85930 (5.4%) | −57.2 | −55.3 | 0.34 |
| MLLT3 SRX10131666 | Bronchial tracheal epithelial cells Lung | 109 / 8593 (1.3%) | 97 / 85930 (0.1%) | −57.1 | −55.3 | 11.24 |
| ERG SRX063917 | MCF-7 Breast | 673 / 8593 (7.8%) | 3291 / 85930 (3.8%) | −57.1 | −55.2 | 2.04 |
| BMI1 SRX8726297 | Tumor Others | 721 / 8593 (8.4%) | 3631 / 85930 (4.2%) | −57.0 | −55.2 | 1.99 |
| FOXA1 SRX5323844 | MCF-7 Breast | 66 / 8593 (0.8%) | 3006 / 85930 (3.5%) | −57.0 | −55.2 | 0.22 |
| STAT5A SRX9681372 | ARP-1 Blood | 647 / 8593 (7.5%) | 3114 / 85930 (3.6%) | −56.9 | −55.1 | 2.08 |
| ESR1 SRX2578880 | MDA-MB-231 Breast | 654 / 8593 (7.6%) | 3163 / 85930 (3.7%) | −56.9 | −55.1 | 2.07 |
| FOXA1 SRX1885182 | LNCAP Prostate | 194 / 8593 (2.3%) | 5160 / 85930 (6.0%) | −56.9 | −55.0 | 0.38 |
| ESR1 SRX3123830 | MCF-7 Breast | 66 / 8593 (0.8%) | 3002 / 85930 (3.5%) | −56.8 | −55.0 | 0.22 |
| KDM5B SRX3285611 | MCF-7 Breast | 581 / 8593 (6.8%) | 2664 / 85930 (3.1%) | −56.8 | −55.0 | 2.18 |
| MBD3 SRX1674506 | HeLa Uterus | 1226 / 8593 (14.3%) | 7479 / 85930 (8.7%) | −56.8 | −55.0 | 1.64 |
| KMT2A SRX8151119 | VDH-15 Others | 897 / 8593 (10.4%) | 4928 / 85930 (5.7%) | −56.8 | −54.9 | 1.82 |
| ESR1 SRX5323872 | MCF-7 Breast | 231 / 8593 (2.7%) | 5711 / 85930 (6.6%) | −56.7 | −54.9 | 0.40 |
| Epitope tags SRX8080559 | Mammary gland adenocarcinoma Breast | 98 / 8593 (1.1%) | 3584 / 85930 (4.2%) | −56.7 | −54.8 | 0.27 |
| JUNB SRX10119395 | MDA-MB-231 Breast | 219 / 8593 (2.5%) | 5531 / 85930 (6.4%) | −56.6 | −54.8 | 0.40 |
| FOXA1 SRX3923531 | ZR-75-1 Breast | 132 / 8593 (1.5%) | 4162 / 85930 (4.8%) | −56.6 | −54.8 | 0.32 |
| CREBBP SRX359409 | 293 Kidney | 743 / 8593 (8.6%) | 3799 / 85930 (4.4%) | −56.6 | −54.8 | 1.96 |
| FOXA1 SRX3931031 | MCF-7 Breast | 114 / 8593 (1.3%) | 3857 / 85930 (4.5%) | −56.6 | −54.7 | 0.30 |
| ESR1 SRX3123823 | MCF-7 Breast | 85 / 8593 (1.0%) | 3344 / 85930 (3.9%) | −56.4 | −54.6 | 0.25 |
| ESR1 SRX20282971 | MCF-7 Breast | 231 / 8593 (2.7%) | 5693 / 85930 (6.6%) | −56.2 | −54.4 | 0.41 |
| ESR1 SRX5534831 | MCF-7 Breast | 181 / 8593 (2.1%) | 4930 / 85930 (5.7%) | −56.2 | −54.4 | 0.37 |
| PHF6 SRX11508322 | G-401 Kidney | 414 / 8593 (4.8%) | 1596 / 85930 (1.9%) | −56.2 | −54.4 | 2.59 |
| ESR1 SRX2513520 | MCF-7 Breast | 151 / 8593 (1.8%) | 4455 / 85930 (5.2%) | −56.2 | −54.3 | 0.34 |
| SETD1A SRX23734380 | MOLM-13 Blood | 485 / 8593 (5.6%) | 2041 / 85930 (2.4%) | −56.2 | −54.3 | 2.38 |
| ESR1 SRX5323871 | MCF-7 Breast | 255 / 8593 (3.0%) | 6042 / 85930 (7.0%) | −56.1 | −54.2 | 0.42 |
| ESR1 SRX5323878 | MCF-7 Breast | 230 / 8593 (2.7%) | 5673 / 85930 (6.6%) | −56.1 | −54.2 | 0.41 |
| SMARCA4 SRX5212362 | Mel270 Others | 391 / 8593 (4.6%) | 7953 / 85930 (9.3%) | −56.0 | −54.2 | 0.49 |
| FOS SRX3322637 | MCF-7 Breast | 129 / 8593 (1.5%) | 4092 / 85930 (4.8%) | −56.0 | −54.2 | 0.32 |
| SOX13 SRX2636248 | Hep G2 Liver | 324 / 8593 (3.8%) | 7021 / 85930 (8.2%) | −55.9 | −54.1 | 0.46 |
Showing first 500 of 23601 rows.